Capital International Sarl’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-19,565	Closed	-$810K	–	211
2022 Q3	$810K	Buy	19,565 +2,035	+12%	+$105K	0.07%	193
2022 Q2	$1.05M	Buy	17,530 +1,446	+9%	+$89K	0.08%	185
2022 Q1	$1.17M	Sell	16,084 -18,722	-54%	-$1.3M	0.06%	222
2021 Q4	$2.93M	Buy	34,806 +25,930	+292%	+$2.11M	0.14%	158
2021 Q3	$801K	Sell	8,876 -1,349	-13%	-$122K	0.07%	181
2021 Q2	$975K	Sell	10,225 -109	-1%	-$11.4K	0.08%	177
2021 Q1	$1.18M	Sell	10,334 -1,608	-13%	-$219K	0.11%	161
2020 Q4	$1.65M	Buy	11,942 +730	+7%	+$86.6K	0.17%	125
2020 Q3	$922K	Buy	11,212 +463	+4%	+$38.4K	0.11%	146
2020 Q2	$841K	Buy	10,749 +1,659	+18%	+$110K	0.11%	149
2020 Q1	$404K	Sell	9,090 -32,159	-78%	-$1.67M	0.07%	155
2019 Q4	$1.76M	Buy	41,249 +4,049	+11%	+$167K	0.27%	101
2019 Q3	$1.59M	Sell	37,200 -14,800	-28%	-$804K	0.27%	102
2019 Q2	$3.3M	Sell	52,000 -21,300	-29%	-$1.36M	0.46%	68
2019 Q1	$5.08M	Buy	73,300 +2,200	+3%	+$126K	0.64%	52
2018 Q4	$3.09M	Sell	71,100 -11,900	-14%	-$650K	0.37%	82
2018 Q3	$6.34M	Buy	83,000 +17,100	+26%	+$1.39M	0.6%	54
2018 Q2	$5.07M	Sell	65,900 -40,950	-38%	-$2.64M	0.51%	57
2018 Q1	$5.45M	Hold	106,850	–	–	0.52%	56
2017 Q4	$4.96M	Sell	106,850 -21,470	-17%	-$1.05M	0.46%	62
2017 Q3	$6.83M	Buy	128,320 +4,000	+3%	+$237K	0.57%	58
2017 Q2	$7.72M	Buy	124,320 +16,870	+16%	+$1.02M	0.67%	49
2017 Q1	$7.28M	Buy	107,450 +16,700	+18%	+$1.27M	0.63%	52
2016 Q4	$6.38M	Buy	90,750 +5,500	+6%	+$390K	0.59%	58
2016 Q3	$6.05M	Buy	+85,250	New	+$5.44M	0.51%	66